Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity (Q40333540)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 October 2006
edit
Language Label Description Also known as
English
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity
scientific article published on 11 October 2006

    Statements

    Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity (English)
    1 reference
    Anna R Thorner
    1 reference
    Diana M Lynch
    1 reference
    Bonnie A Ewald
    1 reference
    Matthew Denholtz
    1 reference
    Menzo J E Havenga
    1 reference
    11 October 2006
    1 reference
    80
    1 reference
    12009-12016
    1 reference
    24
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit